Joe Cook, MD
Pain Medicine · Byram, MSNPI 1285663633
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $18,289 of the $20,932 with a category attached, or 87.4%. Abbott accounts for 60.9% of it on its own, with 27 other manufacturers making up the rest. 2025 is the largest year on record at $4,528, 2.6 times the $1,716 reported in 2019. Among pain medicine clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 395 payments — averaging $52.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$13K
- Spinal Simplicity, LLC$3K
- Medtronic$2K
- Boston Scientific$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$477
- Foundation Fusion Solutions, LLC$425
- plus $2K from 22 others
What the payments were for
- Travel & lodging$2,64313%
- Food & beverage$18,28987%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 221 | $12,752 |
| Spinal Simplicity, LLC | 17 | $2,911 |
| Medtronic(2 entities) | 74 | $1,532 |
| Boston Scientific | 25 | $1,184 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $477 |
| Foundation Fusion Solutions, LLC | 3 | $425 |
| Si-bone, Inc. | 6 | $233 |
| Nalu Medical, Inc. | 3 | $206 |
| Relievant Medsystems, Inc. | 2 | $147 |
| Collegium Pharmaceutical, Inc. | 8 | $134 |
| MDD US Operations, LLC | 1 | $125 |
| Biotronik NRO, Inc. | 2 | $118 |
| Curonix LLC | 2 | $92 |
| Biohaven Pharmaceuticals, Inc. | 5 | $86 |
| MML US, Inc. | 1 | $78 |
| Biodelivery Sciences International, Inc. | 4 | $76 |
| SPR Therapeutics, Inc | 1 | $69 |
| Fidia Pharma USA Inc. | 4 | $66 |
| Stryker | 1 | $34 |
| GRT US Holding, Inc. | 2 | $29 |
| Globus Medical | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Daiichi Sankyo Inc. | 2 | $25 |
| Inari Medical, Inc. | 1 | $19 |
| Vertex | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Proclaim Family of SCS IPGs$2,506
- HA MINUTEMAN G3-R$2,427
- PROCLAIM$1,974
- ETERNA$1,790
- Proclaim IPG$977
- RELISTOR$477
- Intracept$445
- SUPERION$440
- INTELLIS ADAPTIVESTIM$385
- LIBERTY SI$329
- PATRIOT SI$281
- Nalu Neurostimulation System$174
- GENERAL PAIN MANAGEMENT$134
- PRODIGY$127
- Lucemyra/Lofexidine$125
- VANTA ADAPTIVESTIM$116
How this compares
$20,932 in reported general payments places this provider in the 90th percentile of 48 pain medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 503 | $13,070 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 579 | $10,137 |
| Xtampza ErOxycodone Myristate | 14 | $8,983 |
| Fentanyl | 24 | $2,774 |
| Pregabalin | 93 | $2,248 |
| Gabapentin | 136 | $1,430 |
| Oxycodone Hcl | 48 | $1,108 |
| Tramadol Hcl | 102 | $592 |
| Tizanidine Hcl | 82 | $452 |
| Morphine Sulfate ErMorphine Sulfate | 12 | $396 |
| Duloxetine Hcl | 20 | $396 |
| Cyclobenzaprine Hcl | 50 | $318 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 34 | $307 |
| Meloxicam | 31 | $200 |
| Baclofen | 12 | $152 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $134 | $8,98314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 48 pain medicine providers in Mississippi.
Other pain medicine in Byram
- Rayhan TariqLaurel$64K
- Alan TorreyVicksburg$30K
- Landon BurnsFlowood$22K
- Bretley SitzmanHattiesburg$18K
- Michael ScarbroughCorinth$15K
- Casey OrzechowiczJackson$15K
- Anand PremJackson$13K
- Rex WilliamsStarkville$12K
- Jeremy SmithermanFlowood$11K
- Dennis MarceloHattiesburg$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.